Virtual Phase 3 Trial of At-home Light Therapy May Open in Summer 

Virtual Phase 3 Trial of At-home Light Therapy May Open in Summer 

292140

Virtual Phase 3 Trial of At-home Light Therapy May Open in Summer 

PhotoPharmics plans to open, possibly this summer, a pivotal Phase 3 clinical trial of its light-based and noninvasive Celeste device in treating Parkinson’s symptoms, for use by patients at home and with trial goals evaluated using telemedicine. A particular company goal for this device, PhotoPharmics also announced, is reaching underserved patients in more remote areas of the U.S., in keeping with potential changes in Medicare coverage for medical devices. The trial (NCT04453033) — called “Celeste Light for PD Trial”…

You must be logged in to read/download the full post.